Effective Administration of Rituximab in Anti-MDA5 Antibody–Positive Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review

We describe the case of a 48-year-old man with dermatomyositis (DM) who demonstrated rapidly progressive interstitial lung disease (RP-ILD) and refractory cutaneous involvement together with high levels of anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5-Ab). Even after combinatio...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Case Rep Rheumatol
Glavni autori: Ogawa, Yuka, Kishida, Dai, Shimojima, Yasuhiro, Hayashi, Koichi, Sekijima, Yoshiki
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2017
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5684540/
https://ncbi.nlm.nih.gov/pubmed/29225988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5386797
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items